Senior Director, CMC Global Regulatory Affairs

Liquidia is deeply passionate and committed to the discovery, engineering, and development required to bring novel therapies to patients who need them most, and to the healthcare providers who care for them. Our current drive is toward improving the treatment of pulmonary hypertension (PH). We will continue to combine our proprietary, innovative PRINT® Technology with new and established medications, offering the potential for both better precision and improved clinical outcomes.

Our team members include some of the industry’s top scientists, clinicians, business strategists, engineers, and pharmaceutical executives. We work together to help people lead longer, healthier, and happier lives.

The , CMC Global Regulatory Affairs is responsible for leading all regulatory CMC development, registration, and compliance activities from early development through commercialization. This position reports to the Head of Global Regulatory Affairs and may be remote or based at Liquidia in Research Triangle Park, North Carolina.

• Lead development of CMC and device regulatory submission strategies by working closely with colleagues and cross-functional project teams. Review content and maintain submission timelines to meet business objectives.
• Assess and communicate global CMC and device regulatory filing requirements to ensure all development activities comply with applicable regulations and guidelines.
• Work with CMC colleagues to develop Quality by Design (QbD) strategies for novel manufacturing processes. Assist in the conduct and appropriate documentation of all QbD related activities.
• Conduct risk assessments and develop mitigation strategies for global CMC and device regulatory matters.
• Lead and prepare CMC sections of regulatory submissions (NDA/MAA and supplements, IND/CTA, reports or correspondences, annual reports, IND/CTA amendments) and ensure compliance with regulations and standards of health authorities around the world.
• Prepare responses to regulatory authority information requests during the review process to support application approval and maintenance.
• Interface with regulatory agencies on all CMC and device matters and lead preparations for regulatory agency meetings. May also serve as primary contact with FDA for IND/NDA and supplements.
• Effectively communicate novel manufacturing processes and QbD activities to regulatory agencies.
• Work closely with Manufacturing and Quality colleagues and external vendors to prepare for GMP facility inspections by health authorities.
• Assess CMC-related and device changes and ensure those changes are reported in a timely manner to health authorities in accordance with regulatory requirements.
• Maintain and communicate knowledge and impact of relevant global CMC and device regulations, guidelines, and standards.
• Evaluate and communicate risk.

• Bachelor’s degree in chemistry, biochemistry, engineering, life sciences or related field required. Advanced degree preferred. RAC or similar certification a plus.
• For Director, minimum of 10-year CMC regulatory or related experience in the pharmaceutical industry; 12 years for Sr Director; 15 years for Executive Director.
• Demonstrated experience to define and execute CMC regulatory strategies with minimal oversight.
• Strong knowledge of drug development and life cycle management concepts and interdependencies with the overall development process.
• Small molecule experience preferred.
• Understanding of and experience with pharmaceutical QbD concepts and techniques.
• Excellent knowledge of FDA and ICH requirements and guidelines, with experience as FDA liaison;
  Knowledge of EU and other ROW regulations and guidelines preferred.
• Experience in authoring and filing INDs/CTAs/IMPDs and NDAs/MAAs.
• Experience in post-market and commercialization regulatory CMC activities.

• Excellent written and oral communication skills. Demonstrated ability to communicate complex issues to diverse audiences.
• Proven evaluative, analytical, and interpretative skills enabling review and synthesis of information used in regulatory planning and submissions.
• Demonstrated…